$RLMD

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (1y)

—

Win rate (1y)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices delayed ~15 min · refreshed 9m ago

$RLMDSEC Form 4bullish

Shenouda Maged · Chief Financial Officer at RELMADA THERAPEUTICS, INC. · 2h agono track record yet

Long 200,000 shares of RLMD

Bought 200,000 @ $4.22 avg · $843,990 · 2026-09-09

Form 4: Shenouda Maged bought RLMD

Shenouda Maged (Chief Financial Officer at RELMADA THERAPEUTICS, INC.) reported an open-market purchase of 200,000 shares of RLMD at an average $4.22, roughly $843,990, in a Form 4 filed 2026-09-11.

Now $4.429m ago

View filing on SEC.gov →

$RLMDSEC Form 4bullish

TRAVERSA SERGIO · Chief Executive Officer at RELMADA THERAPEUTICS, INC. · 2h agono track record yet

Long 200,000 shares of RLMD

Bought 200,000 @ $4.14 avg · $828,000 · 2026-09-09

Form 4: TRAVERSA SERGIO bought RLMD

TRAVERSA SERGIO (Chief Executive Officer at RELMADA THERAPEUTICS, INC.) reported an open-market purchase of 200,000 shares of RLMD at an average $4.14, roughly $828,000, in a Form 4 filed 2026-09-11.

Now $4.429m ago

View filing on SEC.gov →

End of results.